Injectable Egg-Free Influenza Vaccine 2027
DEPT OF DEFENSE
Free. Verify your email, then we send one reminder only.
- Posted
- Aug 25, 2026
- Closes
- No deadline published by the funder
Similar opportunities open now
- Aviator Breathing Oxygen for Gowen Field, IDSame funderOpenDEPT OF DEFENSECloses in 20 days
- Notice of Intent to Award a Sole Source Contract – Sequencing Bundibugyo virus disease (BDBV) in the 2026 outbreakOpenHEALTH AND HUMAN SERVICES, DEPARTMENT OFNo deadline listed
- 29--FILTER ELEMENT,FLUISame funderOpenDEPT OF DEFENSECloses today
- Q--Virus isolation and molecular RNA analysis services for U.S. Geological SurveyOpenINTERIOR, DEPARTMENT OF THENo deadline listed
At a glance
This is a government contract opportunity posted by DEPT OF DEFENSE in the biological product (except diagnostic) manufacturing category.
Classification and identifiers
- Industry (NAICS)
- Biological Product (except Diagnostic) Manufacturing (325414)
- Product or service (PSC)
- Drugs and Biologicals (6505)
- Solicitation number
- SPE2DP26R0004
- Contracting office
- DLA TROOP SUPPORT
Who can apply
About this opportunity
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Egg-Free Influenza Vaccine for the 2027-2028 flu season. Approximately 300,000 doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be in prefilled syringes presentation. The vaccine shall be FDA-approved for immunizing individuals 18 years and older. The formula for the 2027-2028 season shall be determined by the U.S. Food & Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval, and the vaccine must be U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immu...